Fig. 5From: The prognostic value of a combined immune score in tumor and immune cells assessed by immunohistochemistry in triple-negative breast cancerUnivariate and multivariable Cox proportional hazard models to analyze the prognostic significance of the combined immune score (CIS) groups along with other clinicopathological variables. A and B progression-free survival (PFS), C and D overall-survival (OS)Back to article page